Skip to main content
. 2005 Sep 1;114(2):260–263. doi: 10.1289/ehp.8418

Table 1.

Descriptive statistics for the DVWA concentrations of urinary metabolites for selected OP pesticides in the three study phases.

Study phase No. Frequency of detection (%) Median (μg/L) Mean ± SD (μg/L) Maximum (μg/L)
MDA (LOD = 0.3 μg/L)
 1 87 60 1.5 2.9 ± 5.0* 96.5
 2 116 22 0 0.3 ± 0.9* 7.4
 3 156 60 1.6 4.4 ± 12.4* 263.1
TCPY (LOD = 0.2 μg/L)
 1 87 78 6.0 7.2 ± 5.8** 31.1
 2 116 50 0.9 1.7 ± 2.7** 17.1
 3 155 78 4.3 5.8 ± 5.4** 25.3
IMPY (LOD = 0.7 μg/L)
 1 71 14 0 < LOD ± 0.2 1.2
 2 107 9 0 < LOD ± 0.1 0.4
 3 148 14 0 < LOD ± 1.3 14.6
DEAMPY (LOD = 0.2 μg/L)
 1 70 25 0 0.37 ± 2.2 17.4
 2 103 25 0 < LOD ± 0.1 0.8
 3 146 25 0 < LOD ± 0.3 2.3
CMHC (LOD = 0.2 μg/L)
 1 87 25 0 < LOD ± 0.03 0.2
 2 115 25 0 < LOD ± 0.03 0.2
 3 156 25 0 < LOD ± 0.04 0.2

Abbreviations: CMHC, 3-chloro-4-methyl-7-hydroxycoumarin; DEAMPY, 2-diethylamino-6-methylpyrimidin-4-ol; IMPY, 2-isopropyl-6-methyl-pyrimidin-4-ol; MDA, malathion dicarboxylic acid; TCPY, 3,5,6-trichloro-2-pyridinol.

*Significantly different (one-way ANOVA, p < 0.01; Tukey test, phase 2 level significantly lower than levels in phase 1 and 3).

**Significantly different (one-way ANOVA, p < 0.001; Tukey test, phase 2 level significantly lower than phase 1 and 3 levels).